Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 181Breast Neoplasms 154Prostatic Neoplasms 144Lung Neoplasms 139Glioblastoma 119Head and Neck Neoplasms 115Squamous Cell Carcinoma of Head and Neck 110Rectal Neoplasms 107Lymphoma 101Esophageal Neoplasms 100Pancreatic Neoplasms 76Esophageal Squamous Cell Carcinoma 71Leukemia 70Neoplasms 67Brain Neoplasms 67Lymphoma, Follicular 63Precursor Cell Lymphoblastic Leukemia-Lymphoma 62Lymphoma, Non-Hodgkin 62Lymphoma, Large B-Cell, Diffuse 58Hodgkin Disease 56Uterine Cervical Neoplasms 53Central Nervous System Neoplasms 53Leukemia, Lymphocytic, Chronic, B-Cell 52Gliosarcoma 51Sarcoma 50Colorectal Neoplasms 50Neoplasm Metastasis 45Lymphoma, Large-Cell, Immunoblastic 45Glioma 44Burkitt Lymphoma 43

Interventions

Fulvestrant 6olaparib 4Letrozole 4trastuzumab deruxtecan 3Aromatase Inhibitors 3Anastrozole 3sacituzumab govitecan 2pyrotinib 2eribulin 2dalpiciclib 2Paclitaxel 2Goserelin 2Gonadotropin-Releasing Hormone 2FCN-437c 2Capecitabine 2toripalimab 1talazoparib 1sonidegib 1ribociclib 1pembrolizumab 1neratinib 1liposomal doxorubicin 1elacestrant 1disitamab vedotin 1ceralasertib 1capivasertib 1balixafortide 1apatinib 1abemaciclib 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Breast Cancer × Radiotherapy × Clear all
NCT06776861 2025-01-15

A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting
150 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡